BIONIK LABORATORIES CORP. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
BIONIK LABORATORIES CORP. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$4.95 million for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-21.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2023-06-21
- BIONIK LABORATORIES CORP. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-03-31 was -$1.36M.
- BIONIK LABORATORIES CORP. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-12-31 was -$1.08M.
- BIONIK LABORATORIES CORP. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-09-30 was -$1.13M.
- BIONIK LABORATORIES CORP. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-06-30 was -$1.38M.
- BIONIK LABORATORIES CORP. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$4.95M.
- BIONIK LABORATORIES CORP. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$10.41M.
- BIONIK LABORATORIES CORP. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$13.62M.
- BIONIK LABORATORIES CORP. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$25.02M, a 336.97% decline from fiscal 2019.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21 | -$2.43M derived: sum of 2 quarters · filed 2023-06-21 | -$3.56M derived: sum of 3 quarters · filed 2023-06-21 | -$4.95M 10-K · filed 2023-06-21 | ||||
| 2022-12-31 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-08 | -$2.21M derived: sum of 2 quarters · filed 2023-02-08 | -$3.59M 10-Q · filed 2023-02-08 | -$5.29M derived: sum of 4 quarters · filed 2023-06-21 | ||||
| 2022-09-30 | -$1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | -$2.51M 10-Q · filed 2022-11-09 | -$4.22M derived: sum of 3 quarters · filed 2023-06-21 | -$11.20M derived: sum of 4 quarters · filed 2023-06-21 | ||||
| 2022-06-30 | -$1.38M 10-Q · filed 2022-08-10 | -$3.09M derived: sum of 2 quarters · filed 2023-06-21 | -$10.07M derived: sum of 3 quarters · filed 2023-06-21 | -$11.34M derived: sum of 4 quarters · filed 2023-06-21 | ||||
| 2022-03-31 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21 | -$8.69M derived: sum of 2 quarters · filed 2023-06-21 | -$9.96M derived: sum of 3 quarters · filed 2023-06-21 | -$10.41M 10-K · filed 2023-06-21 | ||||
| 2021-12-31 | -$6.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-08 | -$8.25M derived: sum of 2 quarters · filed 2023-02-08 | -$8.70M 10-Q · filed 2023-02-08 | -$9.74M derived: sum of 4 quarters · filed 2023-02-08 | ||||
| 2021-09-30 | -$1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | -$1.72M 10-Q · filed 2022-11-09 | -$2.75M derived: sum of 3 quarters · filed 2022-11-09 | -$11.70M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$450.91K 10-Q · filed 2022-08-10 | -$1.49M derived: sum of 2 quarters · filed 2022-08-10 | -$10.44M derived: sum of 3 quarters · filed 2022-08-10 | -$12.06M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-09 | -$9.99M derived: sum of 2 quarters · filed 2022-06-09 | -$11.61M derived: sum of 3 quarters · filed 2022-06-09 | -$13.62M 10-K · filed 2022-06-09 | ||||
| 2020-12-31 | -$8.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09 | -$10.58M derived: sum of 2 quarters · filed 2022-02-09 | -$12.59M 10-Q · filed 2022-02-09 | $12.59M 10-Q · filed 2021-02-11 | -$46.08M derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-09-30 | -$1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-10 | -$3.63M 10-Q · filed 2021-11-10 | $3.63M 10-Q · filed 2020-11-12 | -$37.12M derived: sum of 3 quarters · filed 2021-11-10 | -$34.15M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | -$2.01M 10-Q · filed 2021-08-12 | $2.01M 10-Q · filed 2020-08-12 | -$35.50M derived: sum of 2 quarters · filed 2021-08-12 | -$32.53M derived: sum of 3 quarters · filed 2021-08-12 | -$29.14M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | -$33.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-24 | -$30.52M derived: sum of 2 quarters · filed 2021-06-24 | -$27.14M derived: sum of 3 quarters · filed 2021-06-24 | -$25.02M 10-K · filed 2021-06-24 | $25.02M 10-K · filed 2020-06-29 | |||
| 2019-12-31 | $2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-11 | $6.35M derived: sum of 2 quarters · filed 2021-02-11 | $8.47M 10-Q · filed 2021-02-11 | $11.90M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-09-30 | $3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | $5.50M 10-Q · filed 2020-11-12 | $8.93M derived: sum of 3 quarters · filed 2020-11-12 | $11.32M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $2.12M 10-Q · filed 2020-08-12 | $5.55M derived: sum of 2 quarters · filed 2020-08-12 | $7.93M derived: sum of 3 quarters · filed 2020-08-12 | $11.92M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | $3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29 | $5.81M derived: sum of 2 quarters · filed 2020-06-29 | $9.80M derived: sum of 3 quarters · filed 2020-06-29 | $10.56M 10-K · filed 2020-06-29 | ||||
| 2018-12-31 | $2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-14 | $6.37M derived: sum of 2 quarters · filed 2020-02-14 | $7.13M 10-Q · filed 2020-02-14 | |||||
| 2018-09-30 | $3.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-14 | $4.74M 10-Q · filed 2019-11-14 | ||||||
| 2018-06-30 | $760.70K 10-Q · filed 2019-08-12 |